발행물

논문
특허
저서
컨퍼런스

전체 논문

218

11

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
오성용, 강윤구, Li-Tzong Chen, 류민희, 오도연, 오상철, 정현철, 이근욱, Takeshi Omori, Kohei Shitara, Shinichi Sakuramoto, 정익주, Kensei Yamaguchi, Ken Kato, 심선진, Shigenori Kadowaki, Kunihiro Tsuji, Jen-Shi Chen, Li-Yuan Bai, Yasuhiro Choda, Hisateru Yasui, Kentaro Takeuchi, Yoshinori Hirashima, Shunsuke Hagihara, Narikazu Boku
LANCET ONCOLOGY, 2022

12

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)
고세일, 이상철, 배우균, 장대영, 이현우, 장정순, 지준호, 김정훈, 박상곤, 심선진, 양예원, 전소연, 황인규, 강정훈, 오성용
European Journal of Cancer, 2021

13

Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia
이용표, 윤상은, Yuqin Song, 김석진, 윤덕현, Tsai-Yun Chen, 고영일, 강가원, 이호섭, Kevin Tay Kuang Wei, Soon Thye Lim, Michelle Poon, Cosphiadi Irawan, Weili Zhao, 도영록, 이홍기, Soo Chin Ng, 이원식, Ye Guo, Huilai Zhang 18, 강혜진, 윤환중, 김효정, Daryl Tan Chen Lung, 곽재용, 한재준, 문영철, 심혁, 권정혜, 손병석, 박병규, 조재철, 고영혜, Zhu Jun, 김원석, 오성용
International Journal of Hematology, 2021

14

Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia
오성용, 윤상은, Yuqin Song, 김석진, 윤덕현, Tsai-Yun Chen, 고영일, 강가원, 이호섭, Kevin Kuang Wei Tay, Soon Thye Lim, Michele Poon, Cosphiadi Irawan, Weili Zhao, 도영록, 이홍기, Soo Chin Ng, 이원식, Ye Guo, Huilai Zhang, 강혜진, 윤환중, 김효정, Daryl Tan Chen Lung, 곽재용, 한재준, 문영철, 심혁, 권정혜, 손병석, 조재철, 박성규, 고영혜, Zhu Jun, 김원석
Lancet Reg Health West Pac, 2021

15

A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum beta 2-microglobulin levels
오성용, 김형돈, 조형우, 방경혜, 김신, 이경민, 강은희, 박정선, 박찬식, 허주령, 류진숙, 이상욱, 윤덕현, 서철원, 정혜현
BRITISH JOURNAL OF HAEMATOLOGY, 2021

16

Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
오성용, 이준호, 김석진, 윤덕현, 서철원, 장명희, 양덕환, 조재철, 현신영, 엄현석, 이정옥, 권지현, 한상훈, 이승신, 곽재용, 김세형, 김대식, 류헌모, 김효정, 김원석, 이지현
CANCER COMMUNICATIONS, 2021

17

Value Frameworks: Adaptation of Korean Versions of Value Frameworks for Oncology
오성용, 배그린, 배승진, 이동환, 한주희, 구동회, 김도연, 김희준, 이희연, 이종환, 한혜숙, 하혜림, 강진형
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021

18

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
오성용, 박세훈, 임도훈, 손태성, 이지연, 장대영, 김승태, 강정훈, 황인규, 지준호, 신동복, J I Yu, K-M Kim, J Y An, M G Choi, J H Lee, 김성, 홍정용, 박준오, 박영석, 임호영, J M Bae, 강원기
ANNALS OF ONCOLOGY, 2021

19

Relationship between heavy metal exposure and type 2 diabetes: a large-scale retrospective cohort study using occupational health examinations
오성용, Kang, Jung-Hun, Lee, Soon Il, 이수이, 김성현, Ji, Jun Ho, Jin, Mi Hyeon
BMJ Open, 2021

20

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
오성용, 김승태, Sa, Jason K, 김경, 홍정용, 강원기, 김경미, 이지은
GENOME MEDICINE, 2021